Windtree Therapeutics, a Nasdaq-listed biotech firm, plans to purchase up to $700 million in BNB, the fifth-largest cryptocurrency, after it reached a new all-time high. Initially, the company aimed to acquire $200 million worth of BNB and is now raising $520 million to expand its investment. Windtree plans to partner with the crypto exchange Kraken for asset custody. The company is securing funding through a $500 million equity line of credit from an unnamed institutional investor and a $20 million stock purchase agreement with Build and Build Corp. Although Windtree’s stock dipped by 5% recently, it has increased by 162% over the past month. BNB recently achieved a price peak of $808 before experiencing a decline. The initiative aligns Windtree with other publicly traded firms that are adding digital assets to their portfolios, including a recent move by Chinese blockchain company Nano Labs to buy $1 billion in BNB.

Source 🔗